» Articles » PMID: 17984937

In Acromegaly, Increased Bone Mineral Density (BMD) is Determined by GH-excess, Gonadal Function and Gender

Overview
Specialties Endocrinology
Neurology
Date 2007 Nov 7
PMID 17984937
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of our study was to evaluate bone metabolism and bone mineral density (BMD), and to indicate the main determinants of these parameters in a large group of patients with active acromegaly.

Methods: A group of 121 active acromegalics, aged 23-80 years, from a single endocrinological center was studied. Serum GH, IGF-I, LH, FSH, PRL, estradiol/testosterone, osteocalcin (OC), type I collagen carboxyterminal telopeptide (ICTP) as well as BMD by DXA at spine L2-L4, femoral neck, Ward's triangle and trochanter were measured.

Results: Serum OC and ICTP concentrations were elevated (mean+/-SEM: 31.7+/-2.2 microg/L, p<0.001; 7.3+/-0.5 microg/L, p<0.001, respectively), and positively correlated with each other, as well as with IGF-I. BMD (Z-scores) was increased at L2-L4, femoral neck and trochanter (0.35+/-0.15, p=0.016; 0.60+/-0.11, p<0.001 and 0.59+/-0.13, p<0.001; respectively). The main determinants of Z-scores and ICTP were gonadal status and gender, while of OC was IGF-I. Eugonadal acromegalics had higher than normal serum OC and ICTP, as well as Z-scores at all measured sites. Hypogonadal patients (2/3 of the population) had significantly higher serum ICTP concentrations and lower BMD at all sites, when compared to eugonadal acromegalics. Thirty five percent of hypogonadal subjects had T-score<-1. Men had significantly higher serum ICTP and lower Z-scores than women.

Conclusions: (i) In active acromegaly, enhanced IGF-I-dependent bone turnover and increased BMD is observed. (ii) In hypogonadal acromegalics, high bone resorption decreases BMD and may lead to osteoporosis. (iii) There is a smaller increase in bone resorption and greater increase in BMD in women with acromegaly than in men.

Citing Articles

Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly.

Silva F, Lima M, Pedreira C, Matos M J Bone Miner Metab. 2024; .

PMID: 39508862 DOI: 10.1007/s00774-024-01561-z.


Acromegaly and Bone: An Update.

Giustina A Endocrinol Metab (Seoul). 2024; 38(6):655-666.

PMID: 38164073 PMC: 10764988. DOI: 10.3803/EnM.2023.601.


Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients.

Nazzari E, Casabella A, Paolino S, Campana C, Corica G, Nista F J Clin Med. 2022; 11(21).

PMID: 36362602 PMC: 9656167. DOI: 10.3390/jcm11216374.


Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.

Ribeiro de Moura C, Lopes S, Monteiro A Pituitary. 2022; 25(6):780-794.

PMID: 35867180 DOI: 10.1007/s11102-022-01256-6.


Entropy and uniformity as additional parameters to optimize the effectiveness of bone CT in the evaluation of acromegalic patients.

de Castro Dytz O, de Azevedo Berger P, Dytz M, Barbosa B, Jreige Junior A, Reggatieri N Endocrine. 2020; 69(2):368-376.

PMID: 32524503 DOI: 10.1007/s12020-020-02358-6.